Mass spectrometry-based clinical proteomics.

@article{Pusch2003MassSC,
  title={Mass spectrometry-based clinical proteomics.},
  author={Wolfgang Pusch and Mark T. Flocco and Sau-mei Leung and Herbert Thiele and Markus Kostrzewa},
  journal={Pharmacogenomics},
  year={2003},
  volume={4 4},
  pages={463-76}
}
In recent years, mass spectrometry (MS) has been recognized as a 'Gold Standard' tool for the identification and analysis of individual proteins in expression proteomics studies. Moreover, MS has proven useful for the analysis of nucleic acids for single nucleotide polymorphism (SNP) genotyping purposes. With the increased usage of MS as a standard tool for life science applications and the advancement of MS instrumentation, sample preparation and bioinformatics, MS technology has entered novel… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 55 references

Mahoon SM: A comprehensive look at the early detection of ovarian cancer

  • J O’Rourke
  • Clin. J. Oncol. Nurs
  • 2003

An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers

  • F Holding
  • Bioinformatics
  • 2002

Similar Papers

Loading similar papers…